| dc.contributor.author | Zaragoza, Rafael | |
| dc.contributor.author | Estella García, Ángel | |
| dc.contributor.author | Nuvials, Xavier | |
| dc.contributor.author | Robles Plaza, Mireya | |
| dc.contributor.author | Casado Gómez, Araceli | |
| dc.contributor.other | Medicina | es_ES |
| dc.date.accessioned | 2026-11-05T11:11:47Z | |
| dc.date.available | 2026-11-05T11:11:47Z | |
| dc.date.issued | 2026-05-05 | |
| dc.identifier.issn | 2309-608X | |
| dc.identifier.uri | http://hdl.handle.net/10498/40557 | |
| dc.description.abstract | Background: The objective was to identify management strategies of IFI in critically ill patients through a Spanish national survey. Methods: A cross-sectional multicentre survey among ICU specialists, experienced in IFI, was performed (22 April–25 July 2024). The survey consisted of 13 questions with four closed answers. Results: Sixty-three specialists from 51 hospitals of 16 regions completed the survey. 95% stated that, in high-risk patients with clinical suspicion of Pulmonary Aspergillosis (PA), galactomannan in BAL is performed to guide treatment. In the treatment of patients with PA and influenza, 86% declared that isavuconazole and liposomal amphotericin B are recommended treatments and in high suspicion of Aspergillus coinfection, 76% recommended empirical treatment waiting for microbiological confirmation. 90% declared that the use of Extracorporeal Membrane Oxygenation (ECMO) and Renal Replacement Therapies (RRT) could be associated with lower azole levels. Regarding intra-abdominal candidiasis, 78% that physiopathological changes in critically ill patients, reduce their entry into peritoneal fluid. Conclusions: The majority of the respondents agreed (>80%) on: In suspicion of PA, Galactomannan in BAL to guide treatment is mandatory; In case of aspergillosis and influenza, isavuconazole and liposomal amphotericin B are the recommended treatments; The use of ECMO and RRT could be associated with lower azole levels. | es_ES |
| dc.format | application/pdf | es_ES |
| dc.language.iso | eng | es_ES |
| dc.rights | Atribución 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | es_ES |
| dc.source | Journal of Fungi, Vol. 12, Núm. 5, 2026 | es_ES |
| dc.subject | invasive fungal infection | es_ES |
| dc.subject | critically ill patients | es_ES |
| dc.subject | antifungal resistance | es_ES |
| dc.subject | aspergillosis | es_ES |
| dc.subject | candidiasis | es_ES |
| dc.title | IFUCISTRATEGY: A Spanish Survey on the Management of Invasive Fungal Infection (IFI) in Critically Ill Patients | es_ES |
| dc.type | journal article | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.identifier.doi | 10.3390/JOF12050339 | |
| dc.type.hasVersion | VoR | es_ES |